Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Harmony Biosciences Holdings, Inc. - Common Stock
(NQ:
HRMY
)
35.29
UNCHANGED
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harmony Biosciences Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Analyst Ratings For Harmony Biosciences
↗
February 22, 2024
Via
Benzinga
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 22, 2024
From
Harmony Biosciences
Via
GlobeNewswire
The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
↗
February 12, 2024
Small-cap stocks are the first ones to rally on a new business cycle, such as the business cycle starting recently.
Via
InvestorPlace
The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
↗
February 07, 2024
Although the high-flying entities still capture Wall Street’s attention, astute investors should look to undervalued Russell 2000 stocks.
Via
InvestorPlace
NASDAQ:HRMY: good value for what you're paying.
↗
January 25, 2024
In a market where value is scarce, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) offers a refreshing opportunity with its solid fundamentals.
Via
Chartmill
NASDAQ:HRMY stands out as a growth opportunity that won't break the bank.
↗
January 10, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
Via
Chartmill
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 6 Analysts
↗
January 02, 2024
Via
Benzinga
Harmony Biosciences's Earnings Outlook
↗
October 30, 2023
Via
Benzinga
Analyst Ratings for Harmony Biosciences
↗
October 16, 2023
Via
Benzinga
Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents.
↗
January 03, 2024
Don't overlook HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY)—it's a hidden gem with strong fundamentals and an attractive price tag.
Via
Chartmill
Why Harmony Biosciences Stock Got Slammed Today
↗
January 02, 2024
The commercial-stage company was dinged by a bearish new take from a researcher.
Via
The Motley Fool
2023 Year In Review
↗
January 02, 2024
The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%.
Via
Talk Markets
Topics
Stocks
NASDAQ:HRMY is showing good growth, while it is not too expensive.
↗
December 18, 2023
HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
↗
December 17, 2023
While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.
Via
InvestorPlace
NASDAQ:HRMY, an undervalued stock with good fundamentals.
↗
December 13, 2023
When you look at HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via
Chartmill
Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On
↗
December 07, 2023
Although Russell 2000 stocks may operate in the lightweight category, these entities could potentially provide a knockout punch.
Via
InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
↗
November 27, 2023
Investors seeking growth at a reasonable cost should explore HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY).
Via
Chartmill
NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying.
↗
November 22, 2023
HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable.
↗
November 03, 2023
Investors should take note ofHARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), a growth stock that remains attractively priced.
Via
Chartmill
Quick Look At Reports From ServiceNow, Chipotle, And Harmony
↗
November 02, 2023
ServiceNow is a steady, reliable SaaS firm that continues to prove its value and growth potential to investors.
Via
Talk Markets
NASDAQ:HRMY is an undervalued gem with solid fundamentals.
↗
November 01, 2023
For those who appreciate value investing, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a compelling option with its solid fundamentals.
Via
Chartmill
Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript
↗
October 31, 2023
HRMY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
↗
October 31, 2023
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
October 31, 2023
From
Harmony Biosciences
Via
GlobeNewswire
Why Harmony Biosciences Stock Is Trading Higher Today
↗
October 16, 2023
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) shares are trading higher on Monday as the stock rebounds after falling Friday on Phase 3 INTU
Via
Benzinga
Nasdaq Down Over 1%; Wells Fargo Beats Expectations
↗
October 13, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.02% to 33,622.97 while the NASDAQ fell 1.27% to 13,401.56. The S&P...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 13, 2023
Via
Benzinga
Stocks Mixed Amid Earnings, Consumer Sentiment Data
↗
October 13, 2023
Stocks are mixed this afternoon, as investors unpack earnings reports from several bank giants as well as economic data.
Via
Talk Markets
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
October 13, 2023
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today